Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 11 | - |
| 2 | Schedule 2 | FLORENCE INDIALikely | 1 | ₹41,326.20 |
| 3 | Schedule 3 | M/S TRIPTI MEDICAL AGENCYLikely | 1 | ₹18,000 |
| 4 | Schedule 4 | LIFE LINE PHARMACYLikely | 1 | ₹16,902 |
| 5 | Schedule 5 | M/S TRIPTI MEDICAL AGENCYLikely | 1 | ₹3,600 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
9 Jun 2025, 10:00 amClosed
Human Insulin Analogue Glargine Inj 100 IU PER ML Recombinent DNA origin 300 IU DISPOSABLE PEN WITH 5 NEEDLE PER PEN
Tab Midodrine 10 mg
Tab Levocarnitine 500 mg
Tab Variciguat 2.5 mg
Tab Tacrolimus 1 mg
7754742
GEM/2025/B/6153693
Two Packet Bid
Human Insulin Analogue Glargine Inj 100 IU PER ML
30 days
West Bengal; Darjeeling
Item wise evaluation
PRODUCT
6 documents required · 6 mandatory
2 yrs
₹3
30%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Human Insulin Analogue Glargine Inj 100 IU PER ML Recombinent DNA origin 300 IU DISPOSABLE PEN WITH 5 NEEDLE PER PEN | Darjeeling | 270 | 30 days |
| Tab Midodrine 10 mg | Darjeeling | 540 | 30 days |
| Tab Levocarnitine 500 mg | Darjeeling | 6,000 | 30 days |
| Tab Variciguat 2.5 mg | Darjeeling | 180 | 30 days |
| Tab Tacrolimus 1 mg | Darjeeling | 900 | 30 days |
Exempted
9 Jun 2025
19 May 2025
9 Jun 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7754742.pdf
GEM_BID
scanned_document_2025-04-21-09-41-30_d6d9f7cefcb2319190774a1998829509.pdf
BOQ
boq_item_sample_file-2_2025-04-21-09-41-30_5b19e438ba13be69a2d590b89d864f30.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .